Chelsea’s Northera Clears FDA But With A Confirmatory Trial Requirement
This article was originally published in The Pink Sheet Daily
Executive Summary
Northera was approved by FDA under the Subpart H accelerated approval pathway; the Indications and Usage section of the drug’s labeling notes the lack of efficacy data for treatment with the drug beyond two weeks.